Catalyst Wire Dossier Catalyst Wire Dossier

Bupivacaine hydrochloride 0.25%

bupivacaine hydrochloride
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bupivacaine hydrochloride 0.25%, covering 2025-12-15 to 2025-12-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Liposomal Bupivacaine Versus 0.25% Bupivacaine Hydrochloride Post Breast Reduction [Phase 4]

See pricing